Loading...

IDXX IDEXX LABORATORIES INC Management Changes 8-K Filing

DXX

DXX

IDEXX LABORATORIES INC

(IDXX)

2023 8-K

Leadership Change

Board Member Retirement

Financial Results Report

CEO Transition Notice

Credit Facility Update

Quarterly Results

Financial Statements

Management Changes

Financial Statements

Board Resignation

Deferred Compensation Plan

Share Buyback Increase

Board Resignation

Supply Agreement Update

Earnings Correction

Quarterly Results

Financial Results Announcement

Consulting Agreement with J...

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

James F. Polewaczyk, EVP and Chief Commercial Officer of IDEXX Laboratories, Inc., announced his retirement effective April 1, 2024.

AI Assistant

IDEXX LABORATORIES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.